The description of a truncated FGFR1 (also referred to as nFGFR1) as a result of Granzyme B, was described in breast cancer cells and claimed to affect gene expression that altered cell behavior such as invasion [16]. The gene discussed is FGFR1; the disease is breast carcinoma.